TickerFacts.

Bicycle Therapeutics PLC (BCYC): Cash & Equivalents

Annual figures by period end, from SEC filings.

$628.11M
As of 2025-12-31
$510.05M
As of 2026-06-30
+22.8%
3-year compound annual growth
$879.52M2018-12-31: $02019-12-31: $02020-12-31: $02021-12-31: $438.68M2022-12-31: $339.15M2023-12-31: $526.42M2024-12-31: $879.52M2025-12-31: $628.11M$628.11M
2018-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$628.11M-28.6%2026-03-17, Balance as of period end
2024-12-31$879.52M+67.1%2026-03-17, Balance as of period end
2023-12-31$526.42M+55.2%2026-03-17, Balance as of period end
2022-12-31$339.15M-22.7%2025-02-25, Balance as of period end
2021-12-31$438.68Mn/a2024-02-20, Balance as of period end
2020-12-31$0n/a2021-03-11, Balance as of period end
2019-12-31$0n/a2021-03-11, Balance as of period end
2018-12-31$0n/a2020-03-10, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Bicycle Therapeutics PLC (BCYC)2025-12-31$628.11M-28.6%
Assembly Biosciences, Inc. (ASMB)2025-12-31$58.45M+52.4%
AbCellera Biologics Inc. (ABCL)2025-12-31$128.51M-17.8%
Rockwell Medical, Inc. (RMTI)2025-12-31$10.71M-31.6%
CytomX Therapeutics, Inc. (CTMX)2025-12-31$12.67M-66.7%
Kura Oncology, Inc. (KURA)2025-12-31$149.10M-33.6%
Spero Therapeutics, Inc. (SPRO)2025-12-31$40.27M-23.9%
Eton Pharmaceuticals, Inc. (ETON)2025-12-31$25.94M+73.7%
Enanta Pharmaceuticals Inc (ENTA)2025-09-30$32.30M-13.3%

Compare BCYC, ASMB, ABCL, RMTI side by side · Screen every company in Pharmaceutical Preparations ↗